Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer.

Podobné jednotky

• The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen
  Autor: Fox, S, a další
  Vydáno: (2011)
• The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen.
  Autor: Fox, S, a další
  Vydáno: (2011)
• Factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients
  Autor: Generali, D, a další
  Vydáno: (2006)
• Principal factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients.
  Autor: Generali, D, a další
  Vydáno: (2006)
• Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
  Autor: Mele, T, a další
  Vydáno: (2010)